Last week, the U.S. Food & Drug Administration (FDA) decided to allow AquaBounty Technologies, an American company, to commercialize its genetically engineered AquAdvantage Salmon in the U.S. market.
The AquAdvantage Salmon was developed by Massachusetts-based AquaBounty Technologies. It is genetically engineered to reach its market weight in half the time of conventionally raised salmon while using 25% less food and contributing to more sustainable aquaculture systems.
“We are taking another important step by deactivating a 2016 import alert that prevented GE salmon from entering the U.S. The FDA’s approval of the application related to AquAdvantage Salmon followed a comprehensive analysis of the scientific evidence, which determined that the GE Atlantic salmon met the statutory requirements for safety and effectiveness under the Federal Food, Drug, and Cosmetic Act. However, in 2016, Congress directed the FDA not to allow into commerce any food that contains GE salmon until it issued final labeling guidelines for informing consumers of the GE salmon content in the food.… Continue readingRead More »